Feb 15, 2022
Pharmasum Therapeutics has received support from the highly competitive Regional Research Fund for the project “A novel drug for treating dementia in Down syndrome”
READ MORE >>
Dec 16, 2021
Pharmasum Therapeutics presented at the annual DNB Healthcare Venture session
READ MORE >>
Nov 17, 2021
Pharmasum Therapeutics announces the publication of an article titled “Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome” in the journal Pharmaceuticals.
READ MORE >>